-
Mashup Score: 0UPMC Hillman, University of Pittsburgh melanoma researcher receives endowed immunotherapy award - The Cancer Letter - 13 day(s) ago
UPMC Hillman Cancer Center physician scientist and melanoma researcher Yana Najjar, is the 2025 recipient of the Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in cancer immunotherapy. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored […]
Source: cancerletter.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Federal judge rules Trump directives canceling NIH grants “illegal,” orders them to be restored - The Cancer Letter - 13 day(s) ago
A federal judge has called the Trump’s administration’s cancellation of NIH grants “illegal,” striking it down. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
Source: cancerletter.comCategories: General Medicine NewsTweet-
Federal judge rules Trump directives canceling NIH grants “illegal,” orders them to be restored https://t.co/KxDBpR3jFB
-
-
Mashup Score: 0FDA approves Zusduri for intravesical solution in recurrent LG-IR-NMIBC - The Cancer Letter - 14 day(s) ago
FDA has approved Zusduri as the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
FDA approves Zusduri (@UroGenPharma) for intravesical solution in recurrent LG-IR-NMIBC https://t.co/vFIAKFlfRO
-
-
Mashup Score: 2Optimizing dosing of expensive and toxic oncology drugs: Making America healthier - The Cancer Letter - 14 day(s) ago
There is general agreement that the United States spends too much on health care, especially on pharmaceuticals. But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half. Simply stated, cost is the product of (price […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
Optimizing dosing of expensive and toxic oncology drugs: Making America healthier. Written by Mark J. Ratain, MD. https://t.co/TSspcft3K4 https://t.co/z8fHtIQlZX
-
-
Mashup Score: 9From “undruggable” target to clinical potential: The journey of AOH1996 - The Cancer Letter - 15 day(s) ago
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
From “undruggable” target to clinical potential: The journey of AOH1996 @cityofhope https://t.co/b0GwSSGoVz https://t.co/26dj06tCor
-
-
Mashup Score: 0Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures - The Cancer Letter - 15 day(s) ago
For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one… […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures https://t.co/C99nYfY6gm https://t.co/CCaCgw9maQ
-
-
Mashup Score: 0Peter Voorhees named associate director of clinical research at Wake Forest - The Cancer Letter - 15 day(s) ago
Peter Voorhees was promoted to associate director of clinical research and will oversee clinical research for Atrium Health Wake Forest Baptist Comprehensive Cancer Center, as well as all processes related to clinical protocol and data management and protocol review and monitoring system. To access this subscriber-only content please log in or subscribe.If your institution has […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
Peter Voorhees named associate director of clinical research at @AtriumHealthWFB https://t.co/95vXmpwQ4B
-
-
Mashup Score: 1As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention - The Cancer Letter - 15 day(s) ago
As biomedical research at NIH faces an existential threat from the Trump administration, an entrepreneur is winning over allies for what he describes as a “simple idea” that could introduce a massive new infusion of money for innovation in medicine. To access this subscriber-only content please log in or subscribe.If your institution has a site […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention https://t.co/lmcfFQgMEg https://t.co/To5OUFlWxQ
-
-
Mashup Score: 0“Forward funding” NIH budget plan would make competing for grants much harder - The Cancer Letter - 15 day(s) ago
In the fiscal year 2026 budget request, the Trump administration proposes “forward funding,” or multiyear funding, of awards. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
Source: cancerletter.comCategories: General Medicine NewsTweet-
"Forward funding" NIH budget plan would make competing for grants much harder https://t.co/tFpC4YEO85
-
-
Mashup Score: 0
Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. Johnson and Friedberg appear on The Directors, a monthly series on The Cancer Letter […]
Source: cancerletter.comCategories: General Medicine NewsTweet-
Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. What worries them the most? It’s a combination of threats coming from Washington. https://t.co/rOl2qwicJ4 https://t.co/2Byic4qxnD
-
.@UPMCHillmanCC, University of Pittsburgh melanoma researcher receives endowed immunotherapy award https://t.co/jO2hrujKFw